New Key Statistics Module, Z-Score and F-Score
DHA:TECHNODRUG Key Ratios
| Market Cap BDT M | 4,699.14 |
| Enterprise Value BDT M | 6,615.75 |
| P/E(ttm) | 56.67 |
| PE Ratio without NRI | 56.67 |
| Forward PE Ratio | -- |
| Price/Book | 1.19 |
| Price/Sales | 4.62 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) BDT M | 1,020.00 |
| EPS (TTM) BDT | 0.63 |
| Beneish M-Score | 0 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | 37.86 |
| EV-to-EBITDA | 37.86 |
| PEG | -- |
| Shares Outstanding M | 132.00 |
| Net Margin (%) | 7.66 |
| Operating Margin % | 17.10 |
| Pre-tax Margin (%) | 9.43 |
| Quick Ratio | 1.45 |
| Current Ratio | 2.05 |
| ROA % (ttm) | 1.10 |
| ROE % (ttm) | 1.98 |
| ROIC % (ttm) | 2.25 |
| Dividend Yield % | 3.37 |
| Altman Z-Score | -- |
DHA:TECHNODRUG Number of Guru Trades
DHA:TECHNODRUG Volume of Guru Trades
Gurus Latest Trades with DHA:TECHNODRUG
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
DHA:TECHNODRUG is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers